An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This extension study will provide continued onartuzumab and/or parent trial (P-trial) designated control treatments to participants with cancer who were previously enrolled in a company-sponsored onartuzumab P-trial and who derived benefit, as assessed by the responsible investigator, from the therapy administered in the P-trial. The study will also collect safety data with regard to administration of continued onartuzumab therapy.
Epistemonikos ID: b3c158aa145fc820ac1b31be4ebca094798ddb5a
First added on: May 12, 2024